Free Diabetes Screening and Education Event Offers Assistance to More than 50 People in Birmingham
Roche Diabetes Care, Institute for Health Protection and Jefferson State Community College team up to offer free health fair
BIRMINGHAM—More than 50 people attended a free community diabetes program at the Shelby-Hoover campus of Jefferson State Community College on Saturday to learn more about the risk factors for diabetes as well as receive free health screenings. The Institute for Health Protection coordinated the program, which JSCC hosted with support from Roche Diabetes Care, makers of ACCU-CHEK® diabetes products and services.
"Roche is proud to sponsor these free screening and education programs," said Luc Vierstraete, senior vice president and general manager, Roche Diabetes Care North America. "We hope that many members of the community take advantage of these opportunities to learn more about diabetes and how they can live healthier, active lives."
Attendees were offered free and confidential health screenings, free physician consultations and free education materials. They also benefited from clinical and community experts who shared their expertise and perspective during a panel discussion and question and answer session.
"Diabetes is an increasingly important public health issue that effects all Americans," said Alabama State Rep. Mary Sue McClurkin, who attended the fair and spoke on the community expert panel. "I was pleased to see so many people take advantage of the great resources available today to learn more about Type 2 diabetes and how to maintain a healthy, active lifestyle."
The program in Birmingham is part of a series focusing on diabetes that IHP and Roche Diagnostics have been conducting across the country. The overall goal for these programs is to provide educational information for those at risk for developing diabetes as well as those who are currently living with diabetes. In addition to providing free health screenings, a panel of local healthcare providers presents valuable and relevant information. This interactive program provides participants with information and tools to help better manage Type 2 diabetes and/or take measures to prevent its onset.
About Roche Diabetes Care
Roche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 30 years, Roche has been committed to helping people with diabetes live lives that are as normal and active as possible and has been helping healthcare professionals manage their patients’ condition in an optimal way. Today, the ACCU-CHEK portfolio offers people with diabetes and healthcare professionals innovative products, services and comprehensive solutions for convenient, efficient and effective diabetes management—from blood glucose monitoring through information management to insulin delivery. The ACCU-CHEK brand encompasses blood glucose meters, infusion pumps, lancing and data management systems. For more information, please visit accu-chek.com.
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80,000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The Group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com or www.roche-diagnostics.us.
About the Institute for Health Protection
IHP is the premier national organization designed to turn evidence-based healthcare knowledge into everyday practice. Through partnerships with key stakeholders, from the local government to the Morehouse School of Medicine, IHP has been able to develop and execute effective educational programs for improving the health status of diverse communities. For more information about IHP, visit www.ihponline.net.
All trademarks used or mentioned in this release are protected by law.
For further information, please contact:
Todd A. Siesky
Public Relations Manager
Roche Diabetes Care
(317) 521-3966 O
(317) 361-7637 C